Anavex Life Sciences Corp (AVXL)

[georgejjl]

“The consistent efficacy across primary and secondary endpoints in the Phase III AVATAR study confirms the potential of Anavex 2-73 for treating Rett syndrome, which has been suggested by a prior Phase II study,” said Dr. Walter E. Kaufmann, chief scientific officer of Anavex. “Moreover, the convergent clinical evidence is supported by parallel changes in blood-based biomarkers of disease, including the key neurotransmitter GABA. This strong body of data opens the possibility of successful treatment for both adults and children with Rett syndrome and early interventions for modifying the course of the disease.”

https://www.biospace.com/article/anavex-s-rett-syndrome-drug-hits-the-mark-in-phase-iii/

Good luck and GOD bless,